Pilot study of recMAGE-A3 + AS15 ASCL as Consolidation for Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation
ID Number 12-0138Principal Investigator(s)
Hearn Jay Cho
Department(s) or Division(s)
Hematology and Medical Oncology
The purpose of this study is to:
1) Determine the safety and side effects of the Melanoma Antigen Gene (MAGE) vaccination;
2) See how your immune system responds to the MAGE vaccination;
3) See how the MAGE vaccination affects your multiple myeloma.
Because cancer is produced by your own body, your immune system does not easily recognize and fight cancer cells. Your immune system needs to be “trained” to do this. In this study, you are injected with a protein called MAGE that is found in your myeloma cells. We want to see if your body can be trained to recognize this protein and to destroy the myeloma cells that make this protein.
Recruiting Patients: Yes